Coalition for Epidemic Preparedness Innovations & Merck & Co.
2 shared events · Importance 3 · Last updated Jun 03, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Tech
Coalition for Epidemic Preparedness Innovations: The Coalition for Epidemic Preparedness Innovations (CEPI) is a key funder, committing approximately $60 million to accelerate the development of Ebola Bundibugyo vaccines, and is crucial in coordinating the global response.
Merck & Co.: Merck & Co.'s approved vaccine Ervebo for the Zaire strain of Ebola is referenced as a technological precedent for IAVI's Bundibugyo vaccine candidate.
May 22, 2026 · 36 articles
Accidents
Coalition for Epidemic Preparedness Innovations: The Coalition for Epidemic Preparedness Innovations (CEPI) funds vaccine development and is assessing potential Ebola vaccine candidates, aiming for a rapid response.
Merck & Co.: Merck & Co.>>>'s Ervebo vaccine, effective against the Zaire strain of Ebola, is being considered for potential use against the Uganda — Bundibugyo strain, though its efficacy is still under assessment.
May 18, 2026 · 505 articles
NEWSDESK
Explore this relationship live
Track how Coalition for Epidemic Preparedness Innovations and Merck & Co. interact across events, view sentiment trends, and discover connected entities.
Open Dashboard